Bit of a Specter

Ohio State University's Carlo Croce is facing a new set of research misconduct allegations, the New York Times reports.

Over the years, Croce has received millions in grants, numerous awards, and published dozens upon dozens of papers. He's published on the role of genes in cancer development and, more recently, on the role of microRNAs in cancer. Croce is known for making broad claims about his findings, the Times says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.